[1]
R. PRATAP and S. LANKALAPALLI, “DEVELOPMENT AND EVALUATION OF CYCLODEXTRIN NANOSPONGES-BASED TOPICAL FORMULATION OF TAZAROTENE”, Int J App Pharm, vol. 16, no. 6, pp. 90–97, Nov. 2024.